KQSSKALQR
KQSSKALQR is a BCR-ABL peptide. KQSSKALQR can induce CD8+T cell responses. KQSSKALQR can be used in vaccine research for chronic myeloid leukaemia (CML) [1].
Product Specifications
CAS Number
164031-33-8
UNSPSC
12352209
Target
Others
Related Pathways
Others
Field of Research
Cancer
Smiles
[H]N[C@@H](CCCCN)C(N[C@@H](CCC(N)=O)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)C)=O)=O)=O)=O)=O
Molecular Formula
C43H80N16O14
Molecular Weight
1045.19
References & Citations
[1]Rojas JM, et al. Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study. Leukemia. 2007 Nov;21 (11) :2287-95.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC473566-100 1x 100 µL
Annexin A1 / (Hairy Cell Leukemia Marker) (ANXA1/3566), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
